Olsen, Mikkel Thor
Dungu, Arnold Matovu
Klarskov, Carina Kirstine
Jensen, Andreas Kryger
Lindegaard, Birgitte
Kristensen, Peter Lommer
Article History
Received: 9 December 2021
Accepted: 25 February 2022
First Online: 9 March 2022
Declarations
:
: This project has been registered on ClinicalTrials.gov (NCT03795662) and conducted in accordance with the Declaration of Helsinki. Approval was given by the Scientific Ethics Committee of the Capital Region of Denmark with journal number H-18024256 and by the Data Protection Agency with journal number VD-2018-479 with I-Suite number 6738. Informed written consent was obtained from all study participants before entering the study.
: Not applicable.
: MTO: None, AMD: None, CK: None, AKJ: None, BL: None, PLK: Has received speakers fee from Sanofi A/S, Novo Nordisk A/S, Boehringer Ingelheim A/S and AstraZeneca A/S.